JBIO vs RLAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 29, 2026

JBIO

38.3
AI Score
VS
RLAY Wins

RLAY

42.0
AI Score

Investment Advisor Scores

JBIO

38score
Recommendation
AVOID NEW MONEY

RLAY

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric JBIO RLAY Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -48.3% JBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 38.3/100 42.0/100 RLAY
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD RLAY

Relative Price Performance (Last 90 Days)

JBIO 1M: +17.3% · 3M: -31.2% RLAY 1M: +4.6% · 3M: -12.5%

Current Technical Phase

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $16.14

RLAY

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.5%) with fading momentum, RSI 48

RSI (14): 47.9 · Price: $18.09

Fundamentals Snapshot

Metric JBIO RLAY
Market Cap — —
Forward P/E -6.1 -11.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.5%
Gross Margin — -25.8%
Operating Margin 0.0% -30.9%
EPS -1.92 -1.50
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RLAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.